We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 50

India’s guidance for biosimilar drugs draws cautious industry welcome

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • September 20 2012

According to a news source, industry has given India’s new guidelines for biosimilar drugs, launched August 15, 2012, a “cautious welcome.”

India to consider ban on importing animal-tested cosmetics

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • January 9 2014

Following the June 2013 decision to prohibit the testing of domestically produced cosmetics and their ingredients on animals (details about which

India’s Supreme Court orders checks on carbonated soft drinks

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • October 25 2013

India's India’s Supreme Court has reportedly accepted a government scientific panel’s finding that the chemical additives in soft drinks e.g

Indian Parliament considers bill to regulate drugs and cosmetics

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • September 12 2013

Officials in India have introduced a bill that would establish a Central Drugs Authority (CDA) headed by the secretary of health and family

Drug makers complain about slow regulatory approvals in India

  • Shook Hardy & Bacon LLP
  • -
  • Global, India
  • -
  • February 21 2013

Pharmaceutical companies have reportedly begun shifting their clinical trials out of India, claiming that bureaucrats have been slow to approve them

India-based company’s drugs barred from U.S. market

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • January 30 2014

The U.S. Food and Drug Administration (FDA) has prohibited imported drug products from a Ranbaxy Laboratories, Inc. facility in India due to

India biotech sector set to reach $10 billion by 2015

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • May 19 2011

According to a news source, India's biotechnology sector is expected to reach $10 billion in revenue by 2015

India ponders domestic impact of biopharma takeovers

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • March 10 2011

According to a news source, recent takeovers of India's key drug companies by foreign pharmaceutical interests have policymakers worried about the potential impact on domestic drug markets and prices

India Supreme Court requests removal of industry reps from safety enforcement panels

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • February 11 2011

Ruling on a request by a non-governmental organization (NGO), two supreme court justices in India have reportedly asked the government to remove food and soft drink company representatives from food-safety standards and enforcement panels

India issues draft guidelines on clinical trial and data submission requirements for new drug approval

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • August 18 2011

The Central Drugs Standard Control Organization (CDSCO) of India’s Ministry of Health and Family Welfare has issued draft guidelines on the clinical trial and data submission requirements that drug makers must meet before new drugs can be manufactured, marketed or imported into India